Sign In

Paul Rennert

President & CSO at Aleta Biotherapeutics

Paul Rennert is a distinguished Biotechnology Investigator and Executive known for his vast experience in leading the development of small molecule and biologic drugs in areas like oncology, autoimmunity, chronic inflammation, and fibrosis.

His strategic expertise includes therapeutic area analysis, opportunity assessment, due diligence, and aligning research, commercial, and clinical strategies.

Paul's recent achievements involve collaborating with CoStim Pharmaceuticals to prioritize and launch their Cancer Immunotherapeutics portfolio, as well as establishing X-Rx Discovery within X-Chem Inc, focusing on biotechnology assets.

As the CSO of X-Rx Discovery, he oversaw the company's growth from inception to full portfolio execution, leading programs targeting autotaxin and BTK through development stages to IND candidate selection.

Beyond his executive roles, Paul has extensively consulted in academia, biotechnology, and venture capital, contributing to corporate development through research planning, funding identification, and evaluation of therapeutic rationale across various diseases.

He has a strong educational background with degrees from the University of Vermont and Colby College, and has held key positions at organizations like Aleta Biotherapeutics, X-Rx Discovery, SugarCone Biotech Consultants, Biogen Idec, and Repligen Inc.

Paul Rennert
Add to my network

Location

Natick, Massachusetts, United States